Interview Questions137

    Why Distressed Valuation Is Different

    Distressed valuation diverges from healthy-company practice at every step: premise of value, discount rates of 18-30%, and contested projections.

    |
    15 min read
    |
    2 interview questions
    |

    Introduction

    Distressed valuation is a distinct discipline within finance, with methodologies, conventions, and contested-case dynamics that diverge significantly from healthy-company practice. The differences run across every dimension: the premise of value (going concern vs. liquidation), the discount rate calibration (distressed WACCs typically run 18-30%+ versus 8-12% for healthy peers), the selection and adjustment of comparable companies (which may themselves be in decline), the treatment of management projections (typically discounted heavily for optimism bias), and the legal-versus-economic value tension that ultimately produces the recovery waterfall. The result is a valuation practice that requires specialized training, dedicated expertise, and frequent litigation experience because contested cases routinely produce dramatically different valuations from competing experts.

    Recent decades have produced several "battle of the experts" cases that anchor modern distressed valuation practice. The 2003-2005 Mirant Corporation bankruptcy is the canonical example: the April 2005 emergence hearing in Fort Worth featured 11 different expert reports representing the debtors, creditors, equity-holders, and convertible security-holders, with valuations ranging from $7.4 billion at the low end to $13.5 billion at the high end (a $6.1 billion spread that fundamentally affected which creditor classes received equity in the reorganized entity). The 2010-2012 Tribune Company case produced bankruptcy court rejection of competing reorganization plans partly because of flawed valuations from both sides. The Adelphia Communications case produced rulings on the limits of DCF when projections are tainted by fraud. The October 25, 2024 Eletson Holdings ruling by Judge Mastando III in SDNY illustrates that contested valuations continue to produce confirmation denials, in this case under the absolute priority rule analysis.

    This article walks through the core differences between distressed and healthy-company valuation:

    • the premise-of-value choice
    • the discount rate calibration
    • the comparable companies challenges
    • the projection-discount conventions
    • the battle-of-experts dynamic
    • the legal-economic interaction that defines distressed practice

    Each subsequent article in this section addresses specific elements (going concern vs. liquidation, the recovery waterfall, the fulcrum security, claims trading, par-vs-recovery analysis, DCF in distress, the recovery deck) in detail.

    What Distressed Valuation Actually Is

    Distressed Valuation

    The valuation of a financially distressed business or its constituent assets, conducted in connection with restructuring negotiations, Section 363 sales, plan-confirmation proceedings, fresh-start accounting under ASC 852, or distressed credit fund investment decisions. Distressed valuation differs fundamentally from healthy-company valuation in (1) the choice of premise of value (going concern vs. orderly liquidation vs. forced liquidation), (2) the discount rate (typically 18-30% all-in vs. 8-12% for healthy peers, reflecting elevated default risk), (3) the comparable companies framework (which often produces depressed multiples requiring careful selection of less-distressed comparables and adjustment for distress factors), (4) the projection-discount conventions (management projections typically discounted heavily for optimism bias; creditor projections typically discounted for pessimism bias; sensitivity analysis and scenario weighting are standard), and (5) the legal-economic interaction that translates enterprise value into class-by-class recoveries through the absolute priority waterfall. Contested valuations produce ranges of 50%+ in major cases (Mirant 2005: $7.4B-$13.5B, $6.1B spread across 11 experts), making valuation work the most consequential analytical activity in many restructuring engagements.

    The Five Core Differences from Healthy-Company Valuation

    The differences run across every methodological dimension.

    DimensionHealthy-Company ValuationDistressed Valuation
    Premise of valueGoing concern (default assumption)Going concern, orderly liquidation, or forced liquidation, with premise choice driving value swings of 50%+
    Discount rateWACC 8-12% based on stable capital structureAll-in discount rate 18-30%+ reflecting elevated default risk; sometimes derived through option-pricing approaches (Black-Scholes adapted for distressed equity)
    Comparable companiesHealthy peers in the same sectorHealthy peers in adjacent or earlier-stage industries (avoiding the depressed multiples of distressed peers); distress-factor adjustments
    Control premiums20-50% in healthy M&A marketsNear-zero in distressed contexts; sometimes negative for forced sales
    Projection treatmentManagement projections taken at face value (subject to standard skepticism)Heavy projection adjustments; multiple scenarios; downside cases weighted significantly; "creditor case" and "management case" produced separately
    Methodology weightDCF, comparable companies, precedent transactions weighted roughly equallyDCF often dominant for going-concern; asset-based often dominant for liquidation; precedent transactions limited because distressed comps are scarce
    Litigation contextRare; M&A fairness opinions and tax disputesFrequent; plan-confirmation hearings, valuation disputes, fresh-start accounting reviews, fraudulent transfer litigation, recovery analysis disputes
    Outcome useM&A pricing, fairness opinions, financial reportingPlan confirmation, recovery waterfall, fulcrum identification, fresh-start accounting, claims-trading pricing, DIP collateral valuation

    Premise of value

    The going-concern-vs-liquidation choice is the single most consequential decision in distressed valuation. A profitable distressed business typically values higher as a going concern than at liquidation, with the going-concern premium often running 30-100% above orderly liquidation value. A structurally unviable business may value higher in liquidation (if asset values are intact) than as a going concern (if continued operations would consume those asset values). The choice is not merely academic: in Section 363 sales, the going-concern premium drives whether the business is sold to a strategic operator or liquidated through asset auctions. Covered in detail in the going-concern-vs-liquidation article.

    Discount rate calibration

    Healthy-company WACCs run 8-12% for typical mid-cap to large-cap businesses, reflecting stable capital structures and predictable cash flows. Distressed companies require materially higher discount rates because default risk is elevated, cost of debt has risen substantially, and cost of equity reflects the depressed equity value plus the high probability of zero recovery. Modern distressed valuations often produce all-in discount rates of 18-30%, with the highest end (30%+) for severe distress involving strategic deterioration. The Society of Actuaries' 2025 analysis discusses option-pricing approaches (Black-Scholes adapted for distressed equity) that can produce more theoretically rigorous discount rates than traditional CAPM-based approaches in severe-distress contexts.

    Comparable companies

    Healthy comparable companies analysis works because peers in the same sector face similar industry dynamics and produce stable trading multiples. Distressed comparable companies analysis is harder because the natural peer set may itself be in decline, producing depressed multiples that reflect the peers' own impairment. Sophisticated distressed valuations typically use comparable companies from adjacent or earlier-stage industries, with explicit distress-factor adjustments to bridge the comparability gap. Control premiums (which can exceed 50% in frothy M&A markets) collapse toward zero in distressed contexts and can even go negative in forced-sale situations where buyers pay below market for distressed assets.

    The Battle of the Experts

    The most distinctive feature of distressed valuation practice is the prevalence of contested valuations producing dramatically different conclusions from competing experts. The Mirant Corporation case (filed July 14, 2003 with claims exceeding $10 billion) is the canonical modern example. The April 2005 emergence hearing in Fort Worth, Texas featured eleven expert reports representing the debtors, creditors, equity-holders, and convertible security-holders. The valuations ranged from $7.4 billion at the low end to $13.5 billion at the high end, a $6.1 billion spread. The experts differed on nearly every aspect of methodology:

    • which comparable companies to use
    • what discount rate to apply
    • how to weight management projections
    • what control premium (if any) to include
    • how to allocate value across business segments

    The Mirant outcome (which fell between the extremes) was driven by Judge D. Michael Lynn's careful evaluation of each expert's methodology and the bankruptcy court's ultimate determination of which approach best reflected the underlying economics. The case has become a teaching example for how bankruptcy courts navigate competing valuations, with the Stout review of the Mirant valuation jurisprudence and the ABI Journal coverage of the "epic battle of experts" both serving as standard references in the practice.

    Subsequent battle-of-experts cases

    Subsequent cases have produced similar dynamics. The Tribune Company bankruptcy (2008-2012) saw the bankruptcy court decline to confirm competing reorganization plans partly because of flawed valuations from both proponents. The Adelphia Communications case produced rulings on the limits of DCF when underlying cash flow projections are tainted by fraud, with the bankruptcy court finding that the avoidance trust failed to prove insolvency through DCF analysis alone when the projections were unreliable. The Eletson Holdings case (Judge Mastando III, SDNY, October 25, 2024) saw plan confirmation denied based on the absolute priority rule analysis, with the underlying valuation determinations driving the rejection.

    Recent Case Walk-Throughs: Wolfspeed and Eletson

    Wolfspeed (June 30 to September 29, 2025)

    The semiconductor manufacturer's 91-day prepackaged Chapter 11 produced a complete capital structure reset with valuation work supporting each step. The plan reduced total debt from approximately $6.5 billion to $2 billion (a 70% reduction), extended maturities to 2030, and lowered annual cash interest expense by roughly 60%. The pre-petition valuation work supported the plan economics: the $2.127 billion Renesas customer-refundable deposit was converted to a combination of equity and convertible notes; existing shareholders received 5% of the post-emergence equity (with 3% on the effective date and 2% in escrow pending CFIUS clearance); the remaining 95% went to creditors. The valuation work that supported the 5%/95% split was the central economic analysis of the case.

    Eletson Holdings (October 25, 2024)

    Judge John P. Mastando III of SDNY denied confirmation of the debtors' plan of reorganization because it violated the absolute priority rule and the new value exception did not apply. The underlying valuation determinations drove the ruling: the court's view of the company's enterprise value and the resulting recovery waterfall produced impairment of senior classes that the plan structure did not adequately address. The case illustrates how valuation determinations directly translate into legal outcomes through the cramdown framework covered in the absolute priority rule and cramdown article.

    The Process: How Valuation Work Gets Produced

    The valuation work in a contested case runs through a defined sequence over several months.

    1

    Engagement and scope (Weeks 1-2)

    The valuation expert (typically a managing director at the RX bank, sometimes supplemented by a dedicated valuation firm like Stout, Houlihan Lokey valuation, Duff & Phelps, AlixPartners) is engaged with a defined scope of work. Engagement letters typically specify methodologies to be used, the as-of date, the premise of value, and any specific contested issues to address.

    2

    Data gathering and management diligence (Weeks 2-6)

    The expert conducts extensive diligence on the company's financial history, projections, contracts, real estate, intellectual property, and operational metrics. Management interviews are extensive, with multiple sessions typically required to understand industry dynamics, competitive position, and projection assumptions.

    3

    Industry and comparable company research (Weeks 4-8)

    The expert identifies and analyzes comparable companies, screens for distress profiles and operational similarity, and develops the comparable trading-multiple framework. Distressed peers are typically excluded or adjusted; less-distressed peers from adjacent industries are included with explicit adjustment factors.

    4

    DCF model construction (Weeks 6-12)

    The expert builds a comprehensive DCF model with multiple cases (management case, creditor case, downside case), explicit restructuring cost projections, and risk-adjusted discount rates. Sensitivity analysis covers the key value drivers (revenue growth, margin assumptions, terminal value multiple, discount rate).

    5

    Asset-based and liquidation analysis (Weeks 8-12)

    For cases where liquidation is a relevant alternative (typical in retail, manufacturing, real estate-heavy businesses), the expert produces a parallel orderly-liquidation valuation that supports the Section 1129(a)(7) best-interests test and serves as a floor for negotiation.

    6

    Expert report drafting (Weeks 10-14)

    The expert drafts a formal valuation report covering methodology, inputs, conclusions, and supporting analysis. Reports for contested cases typically run 100-300 pages with extensive exhibits.

    7

    Deposition and trial preparation (Weeks 12-20)

    In contested cases, the expert is deposed by opposing counsel and then testifies at the plan confirmation hearing or sale hearing. Cross-examination on methodology, inputs, and conclusions is intensive, with opposing experts typically presenting alternative valuations during their own testimony.

    The Three Standard Methodologies

    Despite the methodological challenges, distressed valuation generally relies on the same three core methodologies as healthy-company valuation: discounted cash flow (DCF), comparable companies analysis, and precedent transactions analysis. The differences are in the inputs, adjustments, and weighting rather than in the underlying frameworks.

    DCF analysis

    Most contested distressed valuations rely heavily on DCF because the methodology lets the analyst incorporate scenario-specific cash flow assumptions and risk-adjusted discount rates. Distressed DCFs typically include explicit restructuring cost projections, multiple scenarios with probability weighting, terminal value calculations using distressed peer multiples or perpetuity growth rates well below GDP, and discount rates derived from build-up methodologies that explicitly address default risk and distressed equity beta. See the DCF in distress article for detail.

    Comparable companies

    Comparable companies analysis is used as a sanity check on DCF outputs and as a primary methodology when DCF is unreliable (e.g., when projections are heavily contested or when the company has limited operating history). The challenge is selecting genuinely comparable peers when the natural peer set is itself in decline. Sophisticated distressed comparables analyses use peers from adjacent industries with similar economic characteristics but different distress profiles, with explicit distress-factor adjustments to bridge the gap.

    Precedent transactions

    Precedent transactions analysis is the weakest methodology in distressed contexts because distressed M&A transactions are relatively rare, the disclosed pricing data is often incomplete, and the transactions reflect specific deal-driven circumstances that may not generalize. Distressed precedent transactions analysis is typically used as a secondary check on the other methodologies rather than as a primary basis for valuation conclusions.

    Asset-based methodologies

    A fourth methodology specific to distressed valuation is asset-based analysis, which estimates value as the sum of identifiable asset values (typically at fair market value or orderly liquidation value) less liabilities. The methodology is most appropriate for severe-distress cases where going-concern continuation is unlikely and the analytical task is estimating recoverable asset value rather than ongoing-business value. Asset-based methodologies are also the foundation for the liquidation analysis required under the Section 1129(a)(7) best-interests-of-creditors test.

    Distressed valuation does not exist in a pure economic vacuum; it operates within a specific legal framework that translates enterprise value determinations into class-by-class recovery outcomes. The recovery waterfall (covered in the recovery waterfall article) allocates the determined enterprise value across the capital structure in legal priority order: secured creditors first up to their collateral value, administrative claims, priority unsecured claims, general unsecured claims, subordinated debt, and equity last. The "fulcrum security" (covered in the fulcrum security article) is the security at which cumulative claims first exceed enterprise value, with holders of the fulcrum typically receiving equity in the reorganized entity.

    The legal-economic interaction means that valuation is not just an analytical exercise but a strategic battleground. A higher enterprise value pushes the fulcrum down the capital structure, giving lower-priority creditors equity participation and reducing impairment of higher-priority creditors. A lower enterprise value pushes the fulcrum up the capital structure, with senior creditors taking equity and junior creditors and equity holders getting wiped out. Each constituency has structural incentive to advocate the enterprise value that maximizes its recovery, which is why contested valuations consistently produce dramatically different conclusions from different experts.

    Distressed valuation is one of the most distinctive analytical practices in finance, and the differences from healthy-company valuation run across every dimension. Understanding the framework, the methodologies, the contested-case dynamics, and the legal-economic interaction is foundational knowledge for restructuring bankers and a defining skill of the practice. The next articles in this section walk through each major component (going concern vs. liquidation, the recovery waterfall, the fulcrum security, claims trading, par-vs-recovery analysis, DCF in distress, the recovery deck) in detail.

    Interview Questions

    2
    Interview Question #1Easy

    How does valuing a distressed company differ from valuing a healthy company?

    Methodologies are similar but assumptions and emphasis differ. DCF: lower-end projections, longer turnaround period, higher WACC (often 12-15% reflecting distress premium), heavier reliance on terminal value. Comps: use the lower end of multiple ranges for healthy peers; sometimes use distressed comps if the sector has restructured peers. Asset-based / liquidation: matters for the first time; sets the floor recovery and underpins the best interests test at confirmation. Adjustments: normalize EBITDA for restructuring fees, professional fees, asset write-downs, abnormal working capital, and lost-customer revenue. Output focus: instead of "what is equity worth," the question becomes "where does value break in the cap stack" (the fulcrum) and "what does each tranche recover."

    Interview Question #2Easy

    Walk me through the "going concern vs liquidation" premise of value.

    Two premises. Going concern: value the company as an operating enterprise that continues post-emergence. Methods: DCF, comps, transaction comps. Output is the enterprise value of the reorganized entity. Used for plan negotiations, fulcrum identification, and recovery analysis under a Chapter 11 plan. Liquidation: value the company as a sale of assets, often piecemeal, in a fire-sale context. Method: asset-by-asset recovery percentages (cash 100%, AR 80%, inventory 50%, PP&E 20-50%, IP varies, brand 0-20%). Output is the liquidation value. Used for the best interests test under Section 1129(a)(7) and as the recovery floor. Going concern almost always exceeds liquidation, which is why most distressed companies pursue Chapter 11 rather than Chapter 7. The gap between the two is the value of organizational capital (employees, customer relationships, brand, supply chain, IP).

    Explore More

    Leveraged Finance Explained: What LevFin Bankers Do

    Leveraged finance explained for IB interviews. How LevFin groups work, the leveraged loan and high-yield bond markets, deal types, career paths, and exit opportunities.

    April 9, 2026

    Net Working Capital Adjustments in M&A Deals Explained

    Master net working capital adjustments in M&A transactions. Learn how NWC targets are set, the adjustment mechanism works, and how buyers and sellers negotiate these critical provisions.

    December 19, 2025

    Hostile Takeovers and Defense Strategies Explained

    Understand hostile takeover tactics and defenses. Learn about tender offers, proxy fights, poison pills, white knights, and how investment banks advise both sides.

    March 16, 2026

    Ready to Transform Your Interview Prep?

    Join 3,000+ students preparing smarter

    Join 3,000+ students who have downloaded this resource